EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metal–Organic Framework as Contrast Agents for Magnetic Resonance Imaging

Weiqi Wang iD, Zijiao Yan, Yajie Yu, Mengjiao Zhou iD, Hejian Xiong iD, Tingting Liu

Pharmaceutics · 19.05.2026 · 18 (5) · 621

DOI: 10.3390/pharmaceutics18050621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 19.05.2026. Verfasst von Weiqi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong 226001, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Scientific Research Project of Nantong Municipal Health Commission, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal–organic frameworks (MOFs) possess unique structural tunability, abundant coordination sites, and outstanding biosafety, rendering them highly advantageous for the development of high-performance magnetic resonance imaging (MRI) contrast agents. In light of the significant advancements in MOF-derived theranostic platforms, a comprehensive overview focusing on their classification and clinically oriented applications is urgently required. This review provides an in-depth examination of various categories of MOF-derived contrast agents, including T1, T2, dual-mode, ratiometric and 19F imaging systems, and analyzes the correlation between structural characteristics and imaging performance. Furthermore, it highlights typical MRI-guided therapeutic applications, such as those related to atherosclerosis, bacterial infections, and cancer immunotherapy. The review systematically addresses existing challenges, including issues related to biodegradability, metabolic behavior, and biosafety. It also summarizes the rational design principles for novel MOF contrast agents, aiming to facilitate their transition from fundamental research to clinical applications.

Schlagwörter

Stichwörter der Autor:innen

biomedical diagnosiscontrast agentmagnetic resonance imagingmetal-organic frameworktheranostic application

Autor:innen und Institutionen

  • School of Pharmacy, Nantong University, Nantong 226001, China.
  • Department of Medical Imaging, Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong Joint Laboratory for Psychiatric Dis…

ORCID-Profile: Weiqi Wang, Mengjiao Zhou, Hejian Xiong

Förderung

  • the Scientific Research Project of Nantong Municipal Health Commission
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Scientific Research Project of Nantong Municipal Health Commission
  • Large Instruments Open Foundation of Nantong University

Zitieren

APA

Wang, W., Yan, Z., Yu, Y., Zhou, M., Xiong, H., & Liu, T. (2026). Metal–Organic Framework as Contrast Agents for Magnetic Resonance Imaging. Pharmaceutics, 18(5), 621. https://doi.org/10.3390/pharmaceutics18050621

Vancouver

Wang W, Yan Z, Yu Y, Zhou M, Xiong H, Liu T. Metal–Organic Framework as Contrast Agents for Magnetic Resonance Imaging. Pharmaceutics. 2026;18(5):621. doi:10.3390/pharmaceutics18050621

BibTeX
@article{Wang2026,
  author = {Wang, Weiqi and Yan, Zijiao and Yu, Yajie and Zhou, Mengjiao and Xiong, Hejian and Liu, Tingting},
  title = {Metal–Organic Framework as Contrast Agents for Magnetic Resonance Imaging},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {621},
  doi = {10.3390/pharmaceutics18050621}
}
Kostenlos starten →